BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1491643)

  • 1. Dose requirement and effect of nicardipine on lipid profile in mild to moderate essential hypertensives.
    Tariq AR; Maheendran K; Kamsiah J; Christina P
    Med J Malaysia; 1992 Sep; 47(3):182-9. PubMed ID: 1491643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twice-daily nicardipine in the treatment of essential hypertension.
    Charlap S; Kimmel B; Laifer L; Weinberg P; Singer M; Lazar E; Saltzberg S; Dorsa F; Kafka K; Strom J
    J Clin Hypertens; 1986 Sep; 2(3):271-7. PubMed ID: 3537214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open assessment of the effect of prazosin on plasma lipids.
    Havard CW; Khokhar AM; Flax JS
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S238-41. PubMed ID: 6177964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrendipine once daily compared with nicardipine in the treatment of mild to moderate hypertension.
    Palermo R; Conti V; Agostinelli MC; Ganzetti S; Racco F; Melappioni A; Pratillo G; Moretti S
    Clin Ther; 1990; 12(2):149-56. PubMed ID: 2354484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
    Bouvier JM; Rabot D; Herrero G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S179-83. PubMed ID: 11527124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicardipine in severe hypertension: oral therapy following intravenous treatment.
    Wallin JD; Bienvenu GS; Cook E; Laddu A; Turlapaty P; Clifton GG
    Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):14-9. PubMed ID: 2303309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of arotinolol on serum lipid and apolipoprotein levels in patients with mild essential hypertension.
    Sasaki J; Handa K; Arakawa K
    Clin Ther; 1989; 11(5):580-3. PubMed ID: 2478285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
    Pathak L; Hiremath ; Kerkar PG; Manade VG
    J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of slow-release nicardipine on blood pressure, renal function and the renin-angiotensin-aldosterone system in patients with mild-to-moderate essential arterial hypertension].
    Melina D; Guerrera G; Santoliquido A; Colivicchi F; Melina G; Musumeci V; Guerrera C
    Clin Ter; 1991 Nov 15-30; 139(3-4):101-6. PubMed ID: 1837249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():52-62. PubMed ID: 11233387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of diltiazem sustained-release and captopril on blood pressure control and plasma lipoproteins in primary hypertension: a randomized, double-blind, crossover study.
    Lacourcière Y; Poirier L; Boucher S; Spenard J
    J Hum Hypertens; 1990 Oct; 4(5):553-6. PubMed ID: 2283645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
    Joglekar SJ; Jaguste V; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of fosinopril on the blood pressure and lipid profile of patients undergoing heart transplantation.
    Almenar L; Osa A; Palencia M; Flores A; Sánchez E
    J Heart Lung Transplant; 1997 Apr; 16(4):454-9. PubMed ID: 9154957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicardipine versus nifedipine: multicentre controlled trial in essential hypertension.
    Rumboldt Z; Stojanova D; Drinovec J; Marinković M; Nesović M; Srbinovski M; Bagatin J; Nikodijević B; Stalc A
    Int J Clin Pharmacol Res; 1988; 8(6):393-400. PubMed ID: 3075601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pinacidil on serum lipid, lipoprotein, and apolipoprotein levels in patients with mild to moderate hypertension.
    Saku K; Ying H; Arakawa K
    Clin Ther; 1990; 12(2):132-8. PubMed ID: 2354482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrendipine and atenolol in essential hypertension in young and middle-aged patients: effect on serum lipids and left ventricular mass.
    López NC; Corral JL; Rincón LA; Arreaza MR; Giralt J; Galué GA; Barrios YE; Arocha I
    J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S101-5. PubMed ID: 1723446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparisons of verapamil administration twice and three times daily in hypertension.
    Salmela PI; Gordin A; Salo H; Ottoila P; Jounela AJ
    Ann Clin Res; 1988; 20(3):195-200. PubMed ID: 3058014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicardipine treatment of hypertension during pregnancy.
    Carbonne B; Jannet D; Touboul C; Khelifati Y; Milliez J
    Obstet Gynecol; 1993 Jun; 81(6):908-14. PubMed ID: 8497354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nicardipine on the metabolic responses to food and exercise.
    Ahmed JH; Elliott HL; Hosie J; Farish E; Reid JL
    J Hum Hypertens; 1992 Apr; 6(2):139-44. PubMed ID: 1597847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antihypertensive effect and tolerability of slow-release nicardipine].
    Fogari R; Poletti L; Tettamanti F; Malamani G; Borgnino C
    Cardiologia; 1989 Feb; 34(2):161-5. PubMed ID: 2660993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.